Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ultrasound watch could save legs after artery surgery

NCT ID NCT06702306

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether adding regular ultrasound scans to standard check-ups helps people who had keyhole surgery for blocked leg arteries. About 70 adults with chronic limb threatening ischaemia will be split into two groups: one gets usual clinic visits, the other gets extra ultrasound scans at 1, 6, and 12 months. The goal is to see if the scans are practical and if they lead to earlier treatment for new blockages.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (18y+) who have had successful lower limb endovascular therapy (angioplasty, stenting, atherectomy, lithotripsy, drug eluting balloon or stent, or combination of above) for chronic limb threatening ischaemia (ischaemic rest pain, ulceration or gangrene with arterial imaging confirming peripheral arterial disease). Technical success is defined as \<30% residual stenosis in the treated segments and patient leaving hospital without a major (above ankle) amputation on study leg * Procedures within the last 3 weeks * Interventions to iliac, femoral, tibial, and pedal vessels alone or in combination * Endarterectomy or cutdown is permissible * Able to give informed consent Exclusion Criteria: * Surgical bypass or endarterectomy alone undertaken * Patient unfit for or does not want any future revascularisation * Need for major amputation due to gas gangrene, severe Charcot deformity, extensive tissue loss with unstable foot, severe pedal disease on angiography or patient request * Patient unwilling or cannot attend further surveillance * Interventions for claudication or acute limb ischaemia or trauma * Patients unable to take any form of antiplatelet therapy (aspirin or clopidogrel) * Prior leg endovascular therapy at same anatomical location in study leg (within 1 year) * Currently taking part in research that may impact on the results, design, or scientific value of this study or other studies that the potential participant may be taking part in.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic limb threatening ischaemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Limb-Threatening Ischemia limb ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mid & South Essex NHS Foundation Trust

    Basildon, Essex, SS16 5NL, United Kingdom